Literature DB >> 10845435

In vivo efficacy of heated and non-heated humidifiers during nasal continuous positive airway pressure (nCPAP)-therapy for obstructive sleep apnoea.

G H Wiest1, F S Fuchs, W M Brueckl, G Nusko, I A Harsch, E G Hahn, J H Ficker.   

Abstract

Upper airway dryness is a frequent side-effect of nasal continuous positive airway pressure therapy (nCPAP) in obstructive sleep apnoea (OSA). In this situation, heated or non-heated passover humidifiers are often added to the nCPAP-therapy. The efficacy of these two modes in terms of increasing the absolute humidity of the inspired air in vivo has so far not been established. The present investigation was therefore designed to compare various heated and non-heated passover humidifiers in terms of the their ability to increase the absolute humidity in the inspired air during nCPAP. In six healthy test individuals, nCPAP-therapy at pressures of 5 mbar and 10 mbar was simulated, and the relative humidity and temperature of the air within the tube at the junction between CPAP tube and mask were measured. In each test person, measurements were carried out both with and without the two heated (HC 100, Fischer&Paykel Inc., New Zealand and HumidAire, ResMed Ltd., Australia) and two non-heated (Oasis and Humidifier, both from Respironics Inc., U.S.A.) passover humidifiers under steady-state conditions. The absolute humidity was calculated from the relative humidity and temperature measurements. The mean (SD) absolute humidity (gm(-3)) in the steady-state was significantly (P<0.05 higher with each of the humidifiers than that calculated when no humidifier was used. The relevant figures were as follows: no humidifier: 10(-2) (1.8) gm(-3) (at 5 mbar)/9.8 (1.8) gm(-3) (at 10 mbar); Humidifier: 16.4 (0.97)/15.6 (1.26); Oasis: 17.3 (0.97)/ 16.7 (0.93); HC100: 26.5 (1.40)/26.2 (1.23); HumidAire: 31.8 (2.50)/30.9 (2.64). The mean increase in absolute humidity (in gm(-3)) with the aid of the heated humidifiers was 16.3 (5 mbar) gm(-3)/16.4 (10 mbar) gm(-3) with HC100 and 21.6/21.1 with HumidAire, and in both cases was clearly and significantly (P=0.028) higher in comparison with the non-heated humidifiers--6.2/5.8 with Humidifier and 7.2/6.9 with Oasis. In terms of the absolute humidity achieved within the CPAP tube system, the heated humidifiers were clearly superior to the non-heated humidifiers. These results were, however, obtained under laboratory conditions, and therefore cannot be translated unreservedly to the situation represented by long-term CPAP-treatment. Furthermore, it is possible that the smaller humidification capacity of the non-heated humidifiers may still suffice to meet the requirements of clinical use in terms of effectively preventing dry airways under CPAP treatment. This point, however, needs further investigation on the basis of long-term clinical studies.

Entities:  

Mesh:

Year:  2000        PMID: 10845435     DOI: 10.1053/rmed.1999.0729

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Effect of tubing condensate on non-invasive positive pressure ventilators tested under simulated clinical conditions.

Authors:  Diana Elizabeth Hart; Mark Forman; Andrew G Veale
Journal:  Sleep Breath       Date:  2010-07-29       Impact factor: 2.816

Review 2.  Clinical review: humidifiers during non-invasive ventilation--key topics and practical implications.

Authors:  Antonio M Esquinas Rodriguez; Raffaele Scala; Arie Soroksky; Ahmed BaHammam; Alan de Klerk; Arschang Valipour; Davide Chiumello; Claude Martin; Anne E Holland
Journal:  Crit Care       Date:  2012-02-08       Impact factor: 9.097

3.  Effects of nasal mask leak and heated humidification on nasal mucosa in the therapy with nasal continuous positive airway pressure (nCPAP).

Authors:  Yvonne Fischer; Tilman Keck; Richard Leiacker; Ajnacska Rozsasi; Gerhard Rettinger; Philipp M Gruen
Journal:  Sleep Breath       Date:  2008-03-01       Impact factor: 2.816

4.  Water content of delivered gases during non-invasive ventilation in healthy subjects.

Authors:  François Lellouche; Salvatore Maurizio Maggiore; Aissam Lyazidi; Nicolas Deye; Solenne Taillé; Laurent Brochard
Journal:  Intensive Care Med       Date:  2009-03-18       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.